Bank of Montreal
MNTA

Bank of Montreal’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Bank of Montreal’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-64,000
Closed -$746K – 4879
2014
Q1 		$746K Buy
64,000
+32,600
+104% +$552K ﹤0.01% 1834
2013
Q4 		$555K Sell
31,400
-53,600
-63% -$901K ﹤0.01% 1758
2013
Q3 		$1.22M Buy
+85,000
New +$1.3M ﹤0.01% 1368

Bank of Montreal's MNTA Position: Q4 2020 in Review

Bank of Montreal sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 8,429 shares — an estimated $442K sold.

Bank of Montreal first reported a position in MNTA in Q2 2013 and held it in 28 quarters. The position peaked at $1.49M in Q3 2018. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.

  • Bank of Montreal reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
  • Bank of Montreal sold 8,429 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $442K.
  • Bank of Montreal first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2013 and held it in 28 quarters.
  • Bank of Montreal's Momenta Pharmaceuticals, Inc. position peaked at $1.49M in Q3 2018.
  • 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.

Based on Bank of Montreal's 13F filing for Q4 2020, filed 12 Feb 2021.